purine has been researched along with Malignant Melanoma in 2 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reports have shown an increased risk of melanoma skin cancer (MSC) with exposure to tumor necrosis factor alpha (TNF-α) inhibitors and non-melanoma skin cancer (NMSC) with thiopurine exposure in inflammatory bowel disease (IBD) patients." | 7.80 | Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. ( Deepak, P; McKenna, MR; Stobaugh, DJ, 2014) |
| "Reports have shown an increased risk of melanoma skin cancer (MSC) with exposure to tumor necrosis factor alpha (TNF-α) inhibitors and non-melanoma skin cancer (NMSC) with thiopurine exposure in inflammatory bowel disease (IBD) patients." | 3.80 | Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. ( Deepak, P; McKenna, MR; Stobaugh, DJ, 2014) |
| "Melanoma is the most aggressive type of skin cancer, leading to metabolic rewiring and enhancement of metastatic transformation." | 1.56 | Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis. ( Benaki, D; Giannopoulou, AF; Gikas, E; Iliou, A; Konstantakou, EG; Kosmopoulou, M; Mikros, E; Panagiotakis, A; Papassideri, IS; Stravopodis, DJ; Velentzas, AD, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosmopoulou, M | 1 |
| Giannopoulou, AF | 1 |
| Iliou, A | 1 |
| Benaki, D | 1 |
| Panagiotakis, A | 1 |
| Velentzas, AD | 1 |
| Konstantakou, EG | 1 |
| Papassideri, IS | 1 |
| Mikros, E | 1 |
| Stravopodis, DJ | 1 |
| Gikas, E | 1 |
| McKenna, MR | 1 |
| Stobaugh, DJ | 1 |
| Deepak, P | 1 |
2 other studies available for purine and Malignant Melanoma
| Article | Year |
|---|---|
Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Topics: Biomarkers; Cell Line, Tumor; Chromatography, Liquid; Discriminant Analysis; Female; Humans; Least-S | 2020 |
Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents; Databases, Fac | 2014 |